Atypical β-adrenoceptors mediating relaxation in the human colon:: Functional evidence for β3-rather than β4-adrenoceptors

被引:16
作者
De Ponti, F [1 ]
Modini, C [1 ]
Gibelli, G [1 ]
Crema, F [1 ]
Frigo, G [1 ]
机构
[1] Univ Pavia, Dept Internal Med & Therapeut, I-27100 Pavia, Italy
关键词
beta(3)-adrenoceptors; smooth muscle; intestinal motility; smooth muscle relaxants;
D O I
10.1006/phrs.1998.0440
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of the present functional study was to assess the role of beta(3)-adrenoceptors in the light of recent findings suggesting the existence of a putative fourth beta-adrenoceptor in adipose and heart tissue. The effect of the non-conventional beta(3)-adrenoceptor partial agonist CGP12177A is resistant to the effect of the beta(3)-adrenoceptor antagonist SR59230A. Under isotonic conditions in circular muscle strips of human distal colon, the concentration-effect relationship of CGP12177A and SR59104A( beta(3)-adrenoceptor agonists), alone and in the presence of CGP20712A( beta(1)-adrenoceptor antagonist) ICI118551 ( beta(2)-adrenoceptor antagonist) and SR59230A, all 0.1 mu M was studied. CGP12177A concentration-dependently relaxed circular muscle strips (pEC(50) = 6.16 +/- 0.05). This effect was left unchanged by beta(1)-/beta(2)-adrenoceptor blockade, but antagonised by SR59230A (pA(2) = 8.12 +/- 0.02). SR59104A concentration-dependently relaxed circular muscle strips (pEC(50) = 5.43 +/- 0.01), an effect that was not significantly affected by pretreatment with CGP20712A and ICI118551, but competitively antagonised by SR59230A (pK(B) = 7.89). Isoprenaline-induced relaxations were antagonised by propranolol with a low pA(2) value (7.76 +/- 0.16). These results provide further evidence for the presence of functional beta(3)-adrenoceptors in the human colon, but do not support a role for an atypical beta-adrenoceptor distinct from the beta(3)-subtype. (C) 1999 Academic Press.
引用
收藏
页码:345 / 348
页数:4
相关论文
共 20 条
[1]   In vitro inhibition of human colonic motility with SR 59119A and SR 59104A:: evidence of a β3-adrenoceptor-mediated effect [J].
Bardou, M ;
Dousset, B ;
Deneux-Tharaux, C ;
Smadja, C ;
Naline, E ;
Chaput, JC ;
Naveau, S ;
Manara, L ;
Croci, T ;
Advenier, C .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 353 (2-3) :281-287
[2]   MEDIATION OF MOST ATYPICAL EFFECTS BY SPECIES HOMOLOGS OF THE BETA(3)-ADRENOCEPTOR [J].
BLIN, N ;
NAHMIAS, C ;
DRUMARE, MF ;
STROSBERG, AD .
BRITISH JOURNAL OF PHARMACOLOGY, 1994, 112 (03) :911-919
[3]  
DePonti F, 1997, TRENDS PHARMACOL SCI, V18, P52
[4]  
DePonti F, 1996, BRIT J PHARMACOL, V117, P1374
[5]   On the presence of a putative fourth β-adrenoceptor in human adipose tissue [J].
Galitzky, J ;
Langin, D ;
Montastruc, JL ;
Lafontan, M ;
Berlan, M .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1998, 19 (05) :164-165
[6]  
GRANNEMAN JG, 1993, MOL PHARMACOL, V44, P264
[7]   Four beta-adrenoceptor subtypes in the mammalian heart [J].
Kaumann, AJ .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1997, 18 (03) :70-76
[8]   Differences between the third cardiac beta-adrenoceptor and the colonic beta(3)-adrenoceptor in the rat [J].
Kaumann, AJ ;
Molenaar, P .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 118 (08) :2085-2098
[9]  
Kelly J, 1997, BRIT J PHARMACOL, V120, pP207
[10]   TISSUE DISTRIBUTION OF BETA-3-ADRENERGIC RECEPTOR MESSENGER-RNA IN MAN [J].
KRIEF, S ;
LONNQVIST, F ;
RAIMBAULT, S ;
BAUDE, B ;
VANSPRONSEN, A ;
ARNER, P ;
STROSBERG, AD ;
RICQUIER, D ;
EMORINE, LJ .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (01) :344-349